Life cycle impacts and environmental fate of pharmaceuticals: Examining the life cycle

Summary and further reading

We have seen in this module the need to take a holistic approach to improving sustainability within the pharmaceutical industry and examine the product as a whole, throughout its entire lifecycle and not solely focusing on the API.

Recommended reading:

http://www.janusinfo.se/Global/Miljo_och_lakemedel/Miljobroschyr_2014_engelsk_webb.pdf

http://www.nature.com/nbt/journal/v31/n2/box/nbt0213-95_BX1.html

W. De Soete, L. Boone, F. Willemse, E. De Meyer, B. Heirman, H. Van Langenhove and J. Dewulf, Environmental resource footprinting of drug manufacturing: Effects of scale-up and tablet dosage, Resources, Conservation and Recycling, 2014, 91, 82-88.

http://www.sduhealth.org.uk/documents/publications/2014%20strategy%20and%20modulesNewFolder/MODULE_carbon_hotspots_FINAL.pdf